rs3211371
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in complete genomics |
| Make rs3211371(C;T) |
| Make rs3211371(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 19 |
| Position | 41016810 |
| Gene | CYP2B6 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs3211371 |
| dbSNP (classic) | rs3211371 |
| ClinGen | rs3211371 |
| ebi | rs3211371 |
| HLI | rs3211371 |
| Exac | rs3211371 |
| Gnomad | rs3211371 |
| Varsome | rs3211371 |
| LitVar | rs3211371 |
| Map | rs3211371 |
| PheGenI | rs3211371 |
| Biobank | rs3211371 |
| 1000 genomes | rs3211371 |
| hgdp | rs3211371 |
| ensembl | rs3211371 |
| geneview | rs3211371 |
| scholar | rs3211371 |
| rs3211371 | |
| pharmgkb | rs3211371 |
| gwascentral | rs3211371 |
| openSNP | rs3211371 |
| 23andMe | rs3211371 |
| SNPshot | rs3211371 |
| SNPdbe | rs3211371 |
| MSV3d | rs3211371 |
| GWAS Ctlg | rs3211371 |
| GMAF | 0.05051 |
| Max Magnitude | 0 |
rs3211371, also known as 1459C>T, is a SNP encoding the CYP2B6*5 allele of the CYP2B6 gene.
[PMID 21886015] Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles
[PMID 19076156
] Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
[PMID 19154420
] The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC.
[PMID 20459744
] Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study.
[PMID 21172166
] Pharmacogenetics of antidepressant response.
[PMID 23249875] Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study
[PMID 24260284
] CYP2B6 Non-Coding Variation Associated with Smoking Cessation Is Also Associated with Differences in Allelic Expression, Splicing, and Nicotine Metabolism Independent of Common Amino-Acid Changes
[PMID 23133420
] Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.
[PMID 25677220
] Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-containing Conditioning and Autologous Transplantation for Lymphoma
[PMID 25428516] Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer
